tirzepatide vials for sale Zepbound Tirzepatide Injection 5 mg/0.5

Patients should be aware of important safety considerations and seek immediate medical attention for persistent severe abdominal pain (with or without vomiting) suggestive of pancreatitis, right upper quadrant pain/fever/jaundice (gallbladder disease), severe or prolonged gastrointestinal symptoms, or signs of dehydration/acute kidney injury

Risk is highest during the initial titration phase and subsequent dose increases, particularly in vulnerable populations such as older adults or those with pre-existing conditions

For example, the mimics may be administered prior to exposure to a drug, chemical or medical procedure that is known or likely to cause neuronal damage

Start at the lowest semaglutide dose regardless of previous tirzepatide dose, and titrate more slowly (every 6 to 8 weeks rather than 4 weeks)